Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anti-CCNQ antibody (30-110 aa) (STJ191695) | Login | Anti-CCNQ antibody (30-110 aa) (STJ191695) | ||||||||||||||||
|
||||||||||||||||||
Anti-SPAG9 antibody (590-670 aa) (STJ191696) | Login | Anti-SPAG9 antibody (590-670 aa) (STJ191696) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAP3K12 antibody (730-810 aa) (STJ191697) | Login | Anti-MAP3K12 antibody (730-810 aa) (STJ191697) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAP3K14 antibody (90-170 aa) (STJ191698) | Login | Anti-MAP3K14 antibody (90-170 aa) (STJ191698) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAP4K2 antibody (400-480 aa) (STJ191699) | Login | Anti-MAP4K2 antibody (400-480 aa) (STJ191699) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAGEA2/MAGEA2B antibody (50-130 aa) (STJ191701) | Login | Anti-MAGEA2/MAGEA2B antibody (50-130 aa) (STJ191701) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAGEA3 antibody (190-270 aa) (STJ191702) | Login | Anti-MAGEA3 antibody (190-270 aa) (STJ191702) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAGEA6 antibody (10-90 aa) (STJ191703) | Login | Anti-MAGEA6 antibody (10-90 aa) (STJ191703) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAGEA8 antibody (1-80 aa) (STJ191704) | Login | Anti-MAGEA8 antibody (1-80 aa) (STJ191704) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAGEA11 antibody (30-110 aa) (STJ191705) | Login | Anti-MAGEA11 antibody (30-110 aa) (STJ191705) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAGEA12 antibody (40-120 aa) (STJ191706) | Login | Anti-MAGEA12 antibody (40-120 aa) (STJ191706) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAGEB2 antibody (30-110 aa) (STJ191707) | Login | Anti-MAGEB2 antibody (30-110 aa) (STJ191707) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAGEB3 antibody (1-80 aa) (STJ191708) | Login | Anti-MAGEB3 antibody (1-80 aa) (STJ191708) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAGEB6 antibody (160-240 aa) (STJ191709) | Login | Anti-MAGEB6 antibody (160-240 aa) (STJ191709) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAGEB10 antibody (40-120 aa) (STJ191710) | Login | Anti-MAGEB10 antibody (40-120 aa) (STJ191710) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAGEB18 antibody (140-220 aa) (STJ191711) | Login | Anti-MAGEB18 antibody (140-220 aa) (STJ191711) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAGED1 antibody (200-280 aa) (STJ191712) | Login | Anti-MAGED1 antibody (200-280 aa) (STJ191712) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAGED2 antibody (120-200 aa) (STJ191713) | Login | Anti-MAGED2 antibody (120-200 aa) (STJ191713) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAGED4/MAGED4B antibody (300-380 aa) (STJ191714) | Login | Anti-MAGED4/MAGED4B antibody (300-380 aa) (STJ191714) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAGEE2 antibody (240-320 aa) (STJ191715) | Login | Anti-MAGEE2 antibody (240-320 aa) (STJ191715) | ||||||||||||||||
|
||||||||||||||||||
Anti-NSMCE3 antibody (110-190 aa) (STJ191716) | Login | Anti-NSMCE3 antibody (110-190 aa) (STJ191716) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAGEH1 antibody (10-90 aa) (STJ191717) | Login | Anti-MAGEH1 antibody (10-90 aa) (STJ191717) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAPK12 antibody (70-150 aa) (STJ191718) | Login | Anti-MAPK12 antibody (70-150 aa) (STJ191718) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAPK13 antibody (200-280 aa) (STJ191719) | Login | Anti-MAPK13 antibody (200-280 aa) (STJ191719) | ||||||||||||||||
|
||||||||||||||||||
Anti-LAMTOR3 antibody (30-110 aa) (STJ191720) | Login | Anti-LAMTOR3 antibody (30-110 aa) (STJ191720) | ||||||||||||||||
|